BI Asset Management Fondsmaeglerselskab’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.7M | Sell |
40,600
-43,266
| -52% | -$12.4M | 0.11% | 157 |
|
|
2025
Q1 | $25.9M | Sell |
83,866
-1,376
| -2% | -$424K | 0.29% | 77 |
|
|
2024
Q4 | $30.1M | Buy |
85,242
+14,964
| +21% | +$5.28M | 0.32% | 66 |
|
|
2024
Q3 | $25.2M | Sell |
70,278
-5,391
| -7% | -$1.93M | 0.44% | 53 |
|
|
2024
Q2 | $24.1M | Buy |
75,669
+51,096
| +208% | +$16.3M | 0.39% | 66 |
|
|
2024
Q1 | $5.65M | Buy |
24,573
+6,708
| +38% | +$1.54M | 0.11% | 155 |
|
|
2023
Q4 | $3.93M | Buy |
17,865
+13,988
| +361% | +$3.08M | 0.08% | 189 |
|
|
2023
Q3 | $876K | Buy |
3,877
+2,955
| +320% | +$668K | 0.02% | 399 |
|
|
2023
Q2 | $204K | Sell |
922
-2,380
| -72% | -$527K | ﹤0.01% | 612 |
|
|
2023
Q1 | $740K | Buy |
3,302
+2,216
| +204% | +$497K | 0.02% | 389 |
|
|
2022
Q4 | $302K | Buy |
+1,086
| New | +$302K | 0.01% | 478 |
|
|
2022
Q3 | – | Sell |
-884
| Closed | -$208K | – | 491 |
|
|
2022
Q2 | $208K | Buy |
+884
| New | +$208K | 0.01% | 398 |
|
|
2019
Q2 | – | Sell |
-1,000
| Closed | -$117K | – | 315 |
|
|
2019
Q1 | $117K | Sell |
1,000
-1,300
| -57% | -$152K | 0.01% | 196 |
|
|
2018
Q4 | $250K | Buy |
+2,300
| New | +$250K | 0.02% | 180 |
|